Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti‐cancer effects and pharmacological properties

C. Hegedüs, Balázs Sarkadi|British Journal of Pharmacology|2009

Cited by 227